

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.38520910 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.94164637 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.94164637 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.78664416 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.49743601 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.45765609 |
| 7 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.25509748 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.12429330 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.10493592 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.10493592 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.09540613 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 5.09540613 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.09540613 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.09540613 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.09540613 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 5.09540613 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.99031305 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.86096159 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.74608433 |
| 20 | detection of other organism (GO:0098543) | 4.65697176 |
| 21 | detection of bacterium (GO:0016045) | 4.61509940 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.56107235 |
| 23 | negative T cell selection (GO:0043383) | 4.36781708 |
| 24 | DNA deamination (GO:0045006) | 4.33543768 |
| 25 | response to peptidoglycan (GO:0032494) | 4.27920388 |
| 26 | negative thymic T cell selection (GO:0045060) | 4.25461668 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.22041987 |
| 28 | ribosomal small subunit assembly (GO:0000028) | 4.21672657 |
| 29 | leukocyte aggregation (GO:0070486) | 4.19322077 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 4.18677520 |
| 31 | response to interleukin-15 (GO:0070672) | 4.14049580 |
| 32 | T cell migration (GO:0072678) | 4.05926572 |
| 33 | regulation of B cell differentiation (GO:0045577) | 4.03355104 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 4.02035611 |
| 35 | positive T cell selection (GO:0043368) | 4.01711980 |
| 36 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.99763894 |
| 37 | sequestering of actin monomers (GO:0042989) | 3.99596929 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.98450865 |
| 39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.94518832 |
| 40 | thymic T cell selection (GO:0045061) | 3.92003352 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.85740182 |
| 42 | respiratory burst (GO:0045730) | 3.80346039 |
| 43 | neutrophil activation (GO:0042119) | 3.79660046 |
| 44 | detection of external biotic stimulus (GO:0098581) | 3.79283691 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 3.77447173 |
| 46 | response to muramyl dipeptide (GO:0032495) | 3.77084879 |
| 47 | interferon-gamma production (GO:0032609) | 3.73852546 |
| 48 | mast cell activation (GO:0045576) | 3.73700374 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.71767626 |
| 50 | viral transcription (GO:0019083) | 3.71209712 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.71079663 |
| 52 | negative regulation of phagocytosis (GO:0050765) | 3.69263195 |
| 53 | regulation of T cell tolerance induction (GO:0002664) | 3.66496371 |
| 54 | positive regulation of lamellipodium assembly (GO:0010592) | 3.65640449 |
| 55 | activated T cell proliferation (GO:0050798) | 3.62697891 |
| 56 | cellular response to zinc ion (GO:0071294) | 3.61595739 |
| 57 | regulation of mast cell degranulation (GO:0043304) | 3.59044247 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.53695929 |
| 59 | response to type I interferon (GO:0034340) | 3.53385128 |
| 60 | T cell selection (GO:0045058) | 3.52184936 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 3.51072392 |
| 62 | translational termination (GO:0006415) | 3.50412930 |
| 63 | type I interferon signaling pathway (GO:0060337) | 3.49759563 |
| 64 | cellular response to type I interferon (GO:0071357) | 3.49759563 |
| 65 | regulation of necroptotic process (GO:0060544) | 3.48835207 |
| 66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.48027052 |
| 67 | response to host immune response (GO:0052572) | 3.46973355 |
| 68 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.46973355 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 3.46874582 |
| 70 | granulocyte activation (GO:0036230) | 3.46832658 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44211514 |
| 72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.43926701 |
| 73 | regulation of tolerance induction (GO:0002643) | 3.43702387 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.43646512 |
| 75 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.43161008 |
| 76 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.38331402 |
| 77 | T cell homeostasis (GO:0043029) | 3.37534482 |
| 78 | detection of biotic stimulus (GO:0009595) | 3.33183573 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 3.28462826 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28137812 |
| 81 | response to host (GO:0075136) | 3.28137812 |
| 82 | response to host defenses (GO:0052200) | 3.28137812 |
| 83 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.26462583 |
| 84 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.26205204 |
| 85 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.26048890 |
| 86 | detection of molecule of bacterial origin (GO:0032490) | 3.25280901 |
| 87 | positive regulation of lamellipodium organization (GO:1902745) | 3.24374114 |
| 88 | barbed-end actin filament capping (GO:0051016) | 3.24076528 |
| 89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21655375 |
| 90 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.21548401 |
| 91 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.21548401 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.20986641 |
| 93 | leukocyte degranulation (GO:0043299) | 3.20033679 |
| 94 | B cell receptor signaling pathway (GO:0050853) | 3.19359104 |
| 95 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.17244934 |
| 96 | negative regulation of innate immune response (GO:0045824) | 3.16739239 |
| 97 | negative regulation of necroptotic process (GO:0060546) | 3.16195889 |
| 98 | response to interferon-beta (GO:0035456) | 3.15668187 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 3.15061254 |
| 100 | T cell receptor signaling pathway (GO:0050852) | 3.12726788 |
| 101 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.12572718 |
| 102 | microglial cell activation (GO:0001774) | 3.11655061 |
| 103 | regulation of response to interferon-gamma (GO:0060330) | 3.11413008 |
| 104 | translational elongation (GO:0006414) | 3.09836759 |
| 105 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.09750521 |
| 106 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.09455689 |
| 107 | defense response to protozoan (GO:0042832) | 3.09348515 |
| 108 | response to protozoan (GO:0001562) | 3.07438630 |
| 109 | positive regulation of mast cell activation (GO:0033005) | 3.07242941 |
| 110 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.05698469 |
| 111 | natural killer cell differentiation (GO:0001779) | 3.04365162 |
| 112 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.03343559 |
| 113 | T cell costimulation (GO:0031295) | 3.03040261 |
| 114 | lymph node development (GO:0048535) | 3.01035429 |
| 115 | regulation of mast cell activation (GO:0033003) | 3.00975404 |
| 116 | cellular extravasation (GO:0045123) | 3.00726694 |
| 117 | mast cell degranulation (GO:0043303) | 3.00697244 |
| 118 | mast cell activation involved in immune response (GO:0002279) | 3.00697244 |
| 119 | response to interferon-alpha (GO:0035455) | 2.99991431 |
| 120 | positive regulation of granulocyte differentiation (GO:0030854) | 2.99899788 |
| 121 | lymphocyte costimulation (GO:0031294) | 2.99107313 |
| 122 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.98513739 |
| 123 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.98513739 |
| 124 | macrophage activation (GO:0042116) | 2.98389591 |
| 125 | regulation of erythrocyte differentiation (GO:0045646) | 2.97661611 |
| 126 | positive regulation of tolerance induction (GO:0002645) | 2.96115503 |
| 127 | germinal center formation (GO:0002467) | 2.95994381 |
| 128 | Peyers patch development (GO:0048541) | 2.94145374 |
| 129 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.94145374 |
| 130 | negative regulation of interleukin-6 production (GO:0032715) | 2.93873021 |
| 131 | protein targeting to ER (GO:0045047) | 2.93526834 |
| 132 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93378809 |
| 133 | B cell mediated immunity (GO:0019724) | 2.93342113 |
| 134 | tolerance induction (GO:0002507) | 2.92931582 |
| 135 | regulation of regulatory T cell differentiation (GO:0045589) | 2.92881958 |
| 136 | cotranslational protein targeting to membrane (GO:0006613) | 2.92621003 |
| 137 | megakaryocyte development (GO:0035855) | 2.92613082 |
| 138 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.91841453 |
| 139 | regulation of necrotic cell death (GO:0010939) | 2.90773988 |
| 140 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90508457 |
| 141 | positive regulation of macrophage differentiation (GO:0045651) | 2.89598390 |
| 142 | cellular response to interferon-beta (GO:0035458) | 2.88671167 |
| 143 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.86155661 |
| 144 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.85297522 |
| 145 | leukocyte cell-cell adhesion (GO:0007159) | 2.84597490 |
| 146 | natural killer cell activation (GO:0030101) | 2.84262575 |
| 147 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84035997 |
| 148 | neutrophil mediated immunity (GO:0002446) | 2.83015498 |
| 149 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.82206910 |
| 150 | positive regulation of isotype switching (GO:0045830) | 2.82137672 |
| 151 | actin nucleation (GO:0045010) | 2.81861887 |
| 152 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.81363975 |
| 153 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.80607979 |
| 154 | regulation of regulated secretory pathway (GO:1903305) | 2.80349077 |
| 155 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.79505266 |
| 156 | mature B cell differentiation involved in immune response (GO:0002313) | 2.79322718 |
| 157 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.79216070 |
| 158 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.79015637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.08015501 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.60047077 |
| 3 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31712546 |
| 4 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.23990179 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.10030047 |
| 6 | * MYC_22102868_ChIP-Seq_BL_Human | 3.01826001 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98758624 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.95136052 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86361720 |
| 10 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.74741086 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72653498 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67688693 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60977381 |
| 14 | * MAF_26560356_Chip-Seq_TH1_Human | 2.54688130 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.51247377 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.48835258 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.45535737 |
| 18 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40819460 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.40607460 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39948584 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.32751517 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26639157 |
| 23 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.25274231 |
| 24 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.25155330 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22936270 |
| 26 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.21074540 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20630006 |
| 28 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20524250 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19007783 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17859827 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17630458 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.16816757 |
| 33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16240427 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11220404 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08769255 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06992760 |
| 37 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99466798 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93770660 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89483585 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88137846 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87611477 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.86534079 |
| 43 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81998465 |
| 44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81308821 |
| 45 | * MAF_26560356_Chip-Seq_TH2_Human | 1.79120627 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78249341 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77741856 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68234908 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63049003 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62405316 |
| 51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60843070 |
| 52 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59221634 |
| 53 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54959709 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54694887 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53188319 |
| 56 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.53043169 |
| 57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.51194587 |
| 58 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51139455 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.51126662 |
| 60 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.48255389 |
| 61 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47955359 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45054893 |
| 63 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44599478 |
| 64 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35747825 |
| 65 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32198017 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31370107 |
| 67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29580984 |
| 68 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27776782 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23021437 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22929417 |
| 71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22163199 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21680719 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.21665407 |
| 74 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20881754 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19703191 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19588626 |
| 77 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.19238140 |
| 78 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.18041259 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17613041 |
| 80 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16696474 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14598240 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14376490 |
| 83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.13677783 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13581956 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13301244 |
| 86 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12669107 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10585983 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10175170 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10036951 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08282994 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07880246 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05955647 |
| 93 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05346781 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05266725 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02437384 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01977684 |
| 97 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01977273 |
| 98 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01239958 |
| 99 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00305126 |
| 100 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.95934036 |
| 101 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95837474 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95290940 |
| 103 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95256876 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94374780 |
| 105 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94273396 |
| 106 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.94262237 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92670627 |
| 108 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90969000 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90756272 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90047475 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89140914 |
| 112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.88423845 |
| 113 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.87608144 |
| 114 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87472287 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86171061 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85951041 |
| 117 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.85210167 |
| 118 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.83051959 |
| 119 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81928095 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81173158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.63701159 |
| 2 | MP0005671_abnormal_response_to | 3.63068836 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.46118942 |
| 4 | MP0000685_abnormal_immune_system | 3.37940382 |
| 5 | MP0009785_altered_susceptibility_to | 3.10354221 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.88422189 |
| 7 | MP0002166_altered_tumor_susceptibility | 2.71586322 |
| 8 | MP0005025_abnormal_response_to | 2.70931079 |
| 9 | MP0001800_abnormal_humoral_immune | 2.69940579 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.56217122 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.55347827 |
| 12 | MP0001819_abnormal_immune_cell | 2.52815620 |
| 13 | MP0002723_abnormal_immune_serum | 2.51359857 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.48206950 |
| 15 | MP0003436_decreased_susceptibility_to | 2.46261018 |
| 16 | MP0002398_abnormal_bone_marrow | 2.43596995 |
| 17 | MP0003724_increased_susceptibility_to | 2.37054376 |
| 18 | MP0002419_abnormal_innate_immunity | 2.33425073 |
| 19 | MP0001790_abnormal_immune_system | 2.32339619 |
| 20 | MP0005387_immune_system_phenotype | 2.32339619 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.29792149 |
| 22 | MP0002405_respiratory_system_inflammati | 2.26284629 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 2.18627122 |
| 24 | MP0003303_peritoneal_inflammation | 2.17512838 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.15063578 |
| 26 | MP0000716_abnormal_immune_system | 2.14790361 |
| 27 | MP0002006_tumorigenesis | 2.10324057 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 2.04162568 |
| 29 | MP0001545_abnormal_hematopoietic_system | 2.04162568 |
| 30 | MP0000689_abnormal_spleen_morphology | 2.02861684 |
| 31 | MP0002722_abnormal_immune_system | 2.02039865 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 2.01642614 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.99229888 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.99135288 |
| 35 | MP0006082_CNS_inflammation | 1.97740566 |
| 36 | MP0004510_myositis | 1.92593213 |
| 37 | MP0001853_heart_inflammation | 1.90388031 |
| 38 | MP0008260_abnormal_autophagy | 1.89195134 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.88929477 |
| 40 | MP0001873_stomach_inflammation | 1.85367770 |
| 41 | MP0002429_abnormal_blood_cell | 1.85106028 |
| 42 | MP0003866_abnormal_defecation | 1.81376767 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.68877511 |
| 44 | MP0005451_abnormal_body_composition | 1.67289722 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.63188533 |
| 46 | MP0004947_skin_inflammation | 1.62952740 |
| 47 | MP0000858_altered_metastatic_potential | 1.60907994 |
| 48 | MP0002933_joint_inflammation | 1.53400828 |
| 49 | MP0000343_altered_response_to | 1.52626155 |
| 50 | MP0000490_abnormal_crypts_of | 1.46154489 |
| 51 | MP0004381_abnormal_hair_follicle | 1.45410029 |
| 52 | MP0008469_abnormal_protein_level | 1.42190082 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.38602706 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.33957586 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.27777637 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.27672786 |
| 57 | MP0009278_abnormal_bone_marrow | 1.25900191 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.24077669 |
| 59 | MP0003448_altered_tumor_morphology | 1.15540569 |
| 60 | MP0001851_eye_inflammation | 1.13769901 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.12924178 |
| 62 | MP0002132_abnormal_respiratory_system | 1.05547612 |
| 63 | MP0004883_abnormal_blood_vessel | 1.05409842 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.03293206 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.02231620 |
| 66 | MP0005410_abnormal_fertilization | 1.00371207 |
| 67 | MP0005310_abnormal_salivary_gland | 0.97162805 |
| 68 | MP0003690_abnormal_glial_cell | 0.97155088 |
| 69 | MP0003279_aneurysm | 0.96990351 |
| 70 | MP0006054_spinal_hemorrhage | 0.93896781 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.93650558 |
| 72 | MP0002009_preneoplasia | 0.91566782 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 0.91506892 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.89085133 |
| 75 | MP0003183_abnormal_peptide_metabolism | 0.88645951 |
| 76 | MP0005390_skeleton_phenotype | 0.87313256 |
| 77 | MP0003646_muscle_fatigue | 0.86216648 |
| 78 | MP0002095_abnormal_skin_pigmentation | 0.85194535 |
| 79 | MP0004130_abnormal_muscle_cell | 0.83388948 |
| 80 | MP0000371_diluted_coat_color | 0.83224086 |
| 81 | MP0009840_abnormal_foam_cell | 0.82932910 |
| 82 | MP0009763_increased_sensitivity_to | 0.80758143 |
| 83 | MP0001663_abnormal_digestive_system | 0.79284925 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.78821745 |
| 85 | MP0003828_pulmonary_edema | 0.78567236 |
| 86 | MP0000604_amyloidosis | 0.75504450 |
| 87 | MP0005164_abnormal_response_to | 0.73805994 |
| 88 | MP0000249_abnormal_blood_vessel | 0.70522747 |
| 89 | MP0005023_abnormal_wound_healing | 0.69894342 |
| 90 | MP0008007_abnormal_cellular_replicative | 0.68758644 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.67789619 |
| 92 | MP0009764_decreased_sensitivity_to | 0.67364112 |
| 93 | MP0003693_abnormal_embryo_hatching | 0.66604901 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.66512722 |
| 95 | MP0008004_abnormal_stomach_pH | 0.64923993 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.64126297 |
| 97 | MP0005166_decreased_susceptibility_to | 0.63951244 |
| 98 | MP0003075_altered_response_to | 0.63876138 |
| 99 | MP0003795_abnormal_bone_structure | 0.62719484 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.61689212 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.61634902 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61071334 |
| 103 | MP0000313_abnormal_cell_death | 0.60051794 |
| 104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58282812 |
| 105 | MP0008874_decreased_physiological_sensi | 0.57965508 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 0.56354846 |
| 107 | MP0010352_gastrointestinal_tract_polyps | 0.56153039 |
| 108 | MP0000609_abnormal_liver_physiology | 0.55771337 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.52130472 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.51115717 |
| 111 | MP0000358_abnormal_cell_content/ | 0.50990038 |
| 112 | MP0003186_abnormal_redox_activity | 0.50896237 |
| 113 | MP0000598_abnormal_liver_morphology | 0.50025587 |
| 114 | MP0004084_abnormal_cardiac_muscle | 0.49890070 |
| 115 | MP0003091_abnormal_cell_migration | 0.49496735 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.49372082 |
| 117 | MP0003045_fibrosis | 0.49323949 |
| 118 | MP0000477_abnormal_intestine_morphology | 0.48395734 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.46732628 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.45750667 |
| 121 | MP0009115_abnormal_fat_cell | 0.44394542 |
| 122 | MP0004858_abnormal_nervous_system | 0.41211661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nasal polyposis (HP:0100582) | 5.05502833 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.81535471 |
| 3 | Abnormality of the nasal mucosa (HP:0000433) | 4.63638560 |
| 4 | Myositis (HP:0100614) | 4.56033931 |
| 5 | Recurrent bronchitis (HP:0002837) | 4.53448938 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.40531718 |
| 7 | IgM deficiency (HP:0002850) | 4.10118950 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.95878959 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.87622610 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.75841886 |
| 11 | T lymphocytopenia (HP:0005403) | 3.74153706 |
| 12 | Thrombocytosis (HP:0001894) | 3.73785293 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.73718641 |
| 14 | Chronic otitis media (HP:0000389) | 3.70926960 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.58955607 |
| 16 | Abnormality of T cells (HP:0002843) | 3.49594542 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.45550568 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.42493134 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.42493134 |
| 20 | Recurrent viral infections (HP:0004429) | 3.32477440 |
| 21 | Bronchitis (HP:0012387) | 3.25040694 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 3.21266770 |
| 23 | Recurrent skin infections (HP:0001581) | 3.17267531 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.12959299 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 3.11208058 |
| 26 | Petechiae (HP:0000967) | 3.08232544 |
| 27 | Prolonged bleeding time (HP:0003010) | 3.08040970 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.02493464 |
| 29 | Urticaria (HP:0001025) | 3.02169028 |
| 30 | Orchitis (HP:0100796) | 2.95236259 |
| 31 | Stomatitis (HP:0010280) | 2.91221574 |
| 32 | Combined immunodeficiency (HP:0005387) | 2.90515564 |
| 33 | Abnormal number of erythroid precursors (HP:0012131) | 2.89487881 |
| 34 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.88478860 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 2.86308851 |
| 36 | Hypoplasia of the thymus (HP:0000778) | 2.85535926 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.84156181 |
| 38 | Hypochromic anemia (HP:0001931) | 2.82868493 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.82745267 |
| 40 | Meningitis (HP:0001287) | 2.82471503 |
| 41 | Keratoconjunctivitis (HP:0001096) | 2.80309790 |
| 42 | Pustule (HP:0200039) | 2.76785967 |
| 43 | Episodic fever (HP:0001954) | 2.73387296 |
| 44 | Thyroiditis (HP:0100646) | 2.73082395 |
| 45 | IgG deficiency (HP:0004315) | 2.63476126 |
| 46 | Epistaxis (HP:0000421) | 2.63071916 |
| 47 | Obstructive lung disease (HP:0006536) | 2.59864056 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59864056 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.59398940 |
| 50 | Hypochromic microcytic anemia (HP:0004840) | 2.52816617 |
| 51 | Impaired platelet aggregation (HP:0003540) | 2.52730499 |
| 52 | Abnormal platelet function (HP:0011869) | 2.52730499 |
| 53 | Optic neuritis (HP:0100653) | 2.52237447 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.52237447 |
| 55 | Leukocytosis (HP:0001974) | 2.49523832 |
| 56 | Pulmonary embolism (HP:0002204) | 2.46081500 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.45418265 |
| 58 | Lymphopenia (HP:0001888) | 2.44849677 |
| 59 | Increased IgM level (HP:0003496) | 2.43087856 |
| 60 | Thoracic kyphosis (HP:0002942) | 2.42767943 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.40684540 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38902178 |
| 63 | Osteomyelitis (HP:0002754) | 2.38001959 |
| 64 | B lymphocytopenia (HP:0010976) | 2.37988976 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.37988976 |
| 66 | Vasculitis (HP:0002633) | 2.37964287 |
| 67 | Chronic diarrhea (HP:0002028) | 2.34018038 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32978483 |
| 69 | Increased serum ferritin (HP:0003281) | 2.32953776 |
| 70 | Albinism (HP:0001022) | 2.32604465 |
| 71 | Anorexia (HP:0002039) | 2.32402646 |
| 72 | Hemoptysis (HP:0002105) | 2.30766175 |
| 73 | Recurrent sinusitis (HP:0011108) | 2.29549193 |
| 74 | Cellulitis (HP:0100658) | 2.27817663 |
| 75 | Amyloidosis (HP:0011034) | 2.26350660 |
| 76 | Abnormality of eosinophils (HP:0001879) | 2.25458966 |
| 77 | Aplastic anemia (HP:0001915) | 2.25034429 |
| 78 | Slow saccadic eye movements (HP:0000514) | 2.24111069 |
| 79 | Sepsis (HP:0100806) | 2.23729654 |
| 80 | Verrucae (HP:0200043) | 2.23482752 |
| 81 | Papilloma (HP:0012740) | 2.23482752 |
| 82 | Chest pain (HP:0100749) | 2.22891720 |
| 83 | Agammaglobulinemia (HP:0004432) | 2.22573041 |
| 84 | Arterial thrombosis (HP:0004420) | 2.19724707 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.17755146 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.13953057 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 2.10447277 |
| 88 | Abnormality of the fingertips (HP:0001211) | 2.09740767 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.09197365 |
| 90 | Pulmonary infiltrates (HP:0002113) | 2.08115069 |
| 91 | Gingivitis (HP:0000230) | 2.06478828 |
| 92 | Gingival bleeding (HP:0000225) | 2.06219414 |
| 93 | Bronchiectasis (HP:0002110) | 2.05420520 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 2.04808241 |
| 95 | Peritonitis (HP:0002586) | 2.04665944 |
| 96 | Colitis (HP:0002583) | 2.04334957 |
| 97 | Autoimmune hemolytic anemia (HP:0001890) | 2.03319519 |
| 98 | Microcytic anemia (HP:0001935) | 2.03116855 |
| 99 | Viral hepatitis (HP:0006562) | 2.02961527 |
| 100 | Fatigue (HP:0012378) | 2.02333452 |
| 101 | Gastrointestinal stroma tumor (HP:0100723) | 2.02218136 |
| 102 | Increased cerebral lipofuscin (HP:0011813) | 2.01520983 |
| 103 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.01515353 |
| 104 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.01515353 |
| 105 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00221067 |
| 106 | Skin ulcer (HP:0200042) | 1.99834517 |
| 107 | Hypoproteinemia (HP:0003075) | 1.99492398 |
| 108 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99000199 |
| 109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99000199 |
| 110 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99000199 |
| 111 | Abnormality of the pleura (HP:0002103) | 1.98621200 |
| 112 | Hepatosplenomegaly (HP:0001433) | 1.96680603 |
| 113 | Glomerulopathy (HP:0100820) | 1.95196181 |
| 114 | Loss of speech (HP:0002371) | 1.94762642 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 1.94605732 |
| 116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93765850 |
| 117 | Muscle fiber atrophy (HP:0100295) | 1.93368733 |
| 118 | Encephalitis (HP:0002383) | 1.93237005 |
| 119 | Chronic sinusitis (HP:0011109) | 1.91159106 |
| 120 | Abnormality of the thoracic spine (HP:0100711) | 1.90836906 |
| 121 | Acne (HP:0001061) | 1.90470293 |
| 122 | Abnormality of the peritoneum (HP:0002585) | 1.89660684 |
| 123 | Mucopolysacchariduria (HP:0008155) | 1.89340883 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89340883 |
| 125 | Hypertensive crisis (HP:0100735) | 1.89039341 |
| 126 | Spondylolisthesis (HP:0003302) | 1.88870602 |
| 127 | Autoimmune thrombocytopenia (HP:0001973) | 1.88291943 |
| 128 | Increased IgE level (HP:0003212) | 1.88114680 |
| 129 | Deformed sella turcica (HP:0002681) | 1.87514457 |
| 130 | Abnormal platelet volume (HP:0011876) | 1.87291015 |
| 131 | Premature loss of primary teeth (HP:0006323) | 1.87238235 |
| 132 | Papilledema (HP:0001085) | 1.86360209 |
| 133 | Granulocytopenia (HP:0001913) | 1.83890888 |
| 134 | Polygenic inheritance (HP:0010982) | 1.83813192 |
| 135 | Eosinophilia (HP:0001880) | 1.83744585 |
| 136 | Hematochezia (HP:0002573) | 1.82068132 |
| 137 | Purpura (HP:0000979) | 1.81586474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.57330966 |
| 2 | TXK | 3.04377201 |
| 3 | PRPF4B | 2.99784719 |
| 4 | ZAP70 | 2.82166498 |
| 5 | KIT | 2.64424983 |
| 6 | JAK3 | 2.61557511 |
| 7 | NME2 | 2.48742812 |
| 8 | EEF2K | 2.47018334 |
| 9 | TBK1 | 2.43898989 |
| 10 | TRIB3 | 2.42930973 |
| 11 | TYK2 | 2.38994054 |
| 12 | IKBKE | 2.16323658 |
| 13 | PKN2 | 2.12197651 |
| 14 | ERN1 | 2.12195137 |
| 15 | FLT3 | 1.99059314 |
| 16 | BTK | 1.97401695 |
| 17 | TEC | 1.89554085 |
| 18 | PIM2 | 1.89539262 |
| 19 | MAP3K12 | 1.81920797 |
| 20 | KDR | 1.81156003 |
| 21 | MAP2K3 | 1.59165591 |
| 22 | FGFR4 | 1.56176161 |
| 23 | ITK | 1.56104208 |
| 24 | LRRK2 | 1.54866592 |
| 25 | SIK3 | 1.50230366 |
| 26 | SYK | 1.44984640 |
| 27 | MAP3K3 | 1.39347522 |
| 28 | TGFBR2 | 1.36963041 |
| 29 | IRAK4 | 1.36779809 |
| 30 | MAP3K10 | 1.36123687 |
| 31 | BLK | 1.36038878 |
| 32 | STK10 | 1.33618752 |
| 33 | LCK | 1.32783575 |
| 34 | JAK1 | 1.29194242 |
| 35 | GRK6 | 1.29186921 |
| 36 | SCYL2 | 1.27663687 |
| 37 | TTN | 1.26755173 |
| 38 | ACVR1B | 1.25970723 |
| 39 | CSF1R | 1.23156963 |
| 40 | FGR | 1.22157886 |
| 41 | IKBKB | 1.20881065 |
| 42 | MAP3K1 | 1.17944743 |
| 43 | SMG1 | 1.16234382 |
| 44 | MARK2 | 1.15207274 |
| 45 | MAPKAPK3 | 1.14540356 |
| 46 | NLK | 1.14282707 |
| 47 | HCK | 1.12683631 |
| 48 | MYLK | 1.09237675 |
| 49 | CSK | 1.08091809 |
| 50 | PRKD2 | 1.02603474 |
| 51 | TESK1 | 1.02092775 |
| 52 | KSR2 | 1.00208696 |
| 53 | SIK1 | 0.99376306 |
| 54 | TGFBR1 | 0.97175029 |
| 55 | RPS6KA4 | 0.95633211 |
| 56 | TESK2 | 0.95423224 |
| 57 | STK16 | 0.94827741 |
| 58 | FES | 0.93807783 |
| 59 | TAOK3 | 0.93489773 |
| 60 | FGFR3 | 0.92589727 |
| 61 | PIM1 | 0.87436226 |
| 62 | CAMKK1 | 0.87152474 |
| 63 | MAP3K11 | 0.85690174 |
| 64 | JAK2 | 0.82829132 |
| 65 | ILK | 0.82527234 |
| 66 | MAPK12 | 0.82308096 |
| 67 | TNK2 | 0.81062380 |
| 68 | CDC42BPA | 0.80093150 |
| 69 | PAK4 | 0.79829931 |
| 70 | MAP3K14 | 0.79330106 |
| 71 | IRAK3 | 0.78797578 |
| 72 | LYN | 0.78120811 |
| 73 | RIPK4 | 0.77812731 |
| 74 | DMPK | 0.77322189 |
| 75 | PDPK1 | 0.76828526 |
| 76 | TAOK2 | 0.75518216 |
| 77 | MAP3K13 | 0.75466184 |
| 78 | BCKDK | 0.73120469 |
| 79 | CDK12 | 0.71656677 |
| 80 | YES1 | 0.67952300 |
| 81 | RAF1 | 0.67484297 |
| 82 | IRAK2 | 0.66891084 |
| 83 | MAPK7 | 0.66807210 |
| 84 | PRKG2 | 0.66054410 |
| 85 | MAP2K2 | 0.65459954 |
| 86 | PDK1 | 0.64521224 |
| 87 | PDK4 | 0.63508118 |
| 88 | PDK3 | 0.63508118 |
| 89 | MAP2K6 | 0.63359965 |
| 90 | MAPK11 | 0.62891831 |
| 91 | TAOK1 | 0.62406121 |
| 92 | DYRK3 | 0.60065828 |
| 93 | FYN | 0.59738484 |
| 94 | IRAK1 | 0.59023605 |
| 95 | PASK | 0.58722111 |
| 96 | DYRK1B | 0.58178251 |
| 97 | NEK2 | 0.57752741 |
| 98 | HIPK2 | 0.56840100 |
| 99 | MAP3K7 | 0.56793939 |
| 100 | SIK2 | 0.56228343 |
| 101 | MAP3K6 | 0.56074905 |
| 102 | RIPK1 | 0.54916016 |
| 103 | MATK | 0.53534812 |
| 104 | CDK19 | 0.52419846 |
| 105 | MUSK | 0.51489599 |
| 106 | CDK4 | 0.50290583 |
| 107 | EPHB1 | 0.49963891 |
| 108 | MAPK4 | 0.49490564 |
| 109 | RPS6KB2 | 0.48665849 |
| 110 | STK11 | 0.48582221 |
| 111 | RET | 0.48314021 |
| 112 | DAPK3 | 0.48200315 |
| 113 | STK38 | 0.45790781 |
| 114 | DAPK1 | 0.45426668 |
| 115 | RPS6KA6 | 0.43622552 |
| 116 | PTK6 | 0.42697020 |
| 117 | ICK | 0.42617407 |
| 118 | LMTK2 | 0.40730886 |
| 119 | NEK9 | 0.40165619 |
| 120 | CAMKK2 | 0.39837111 |
| 121 | PIK3CG | 0.39590165 |
| 122 | BMPR2 | 0.39175922 |
| 123 | RPS6KL1 | 0.36996223 |
| 124 | RPS6KC1 | 0.36996223 |
| 125 | SGK3 | 0.36586274 |
| 126 | PRKCQ | 0.35750927 |
| 127 | PTK2B | 0.34871891 |
| 128 | MARK3 | 0.34071010 |
| 129 | ADRBK2 | 0.33878764 |
| 130 | CAMK4 | 0.33519543 |
| 131 | MAPKAPK2 | 0.33468920 |
| 132 | MAP3K5 | 0.33271786 |
| 133 | CDK6 | 0.33002152 |
| 134 | CHUK | 0.31094958 |
| 135 | PRKCH | 0.30528515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.31752905 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.82185759 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66527836 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.65560062 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.64390902 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.62089833 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.43101804 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32668522 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30013593 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.23910096 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.14053755 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04945043 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01349493 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98997708 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86505259 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81262592 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.79040949 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.65795792 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62415660 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59955365 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.59351171 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.57826825 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44647019 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41458538 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.41128373 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.40039237 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39873299 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.38574129 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35474224 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34404092 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29685336 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.28689868 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.28014062 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27685405 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.24765665 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23667243 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23099281 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.22979301 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.22834823 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.19587503 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.18594345 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.12854397 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09727904 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.08269844 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.05850985 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05134934 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03462882 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00681515 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00059704 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98747315 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97178440 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.96682034 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.92121181 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91152024 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89609232 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88969098 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88502624 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87622896 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85365198 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84892686 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84006245 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82835488 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82409333 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81764289 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81631299 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.79011792 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78814928 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78769293 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 0.76219987 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76168153 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73906486 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72778329 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72385061 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71935782 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71247062 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70545173 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67713355 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66478882 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66156591 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64654826 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62525422 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61848093 |
| 83 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60658060 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60416052 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60379621 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59471634 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58296652 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.57063973 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56807298 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55898771 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55887046 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54717539 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.49761969 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48641837 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48558510 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46990539 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.46745325 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46744039 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46719471 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.46014895 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45885095 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45197633 |
| 103 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44972511 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44941571 |
| 105 | Amoebiasis_Homo sapiens_hsa05146 | 0.44608926 |
| 106 | Spliceosome_Homo sapiens_hsa03040 | 0.44126377 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42329775 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41452267 |
| 109 | Mismatch repair_Homo sapiens_hsa03430 | 0.40152363 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38760260 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.37831376 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.37565575 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37089985 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35760490 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35108105 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.34001075 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31640809 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31275061 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31139129 |
| 120 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.28981575 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23924686 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23766325 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.21062612 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.20416664 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20318870 |
| 126 | Proteasome_Homo sapiens_hsa03050 | 0.19519269 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18166187 |

